Premium
[O2–09–04]: PHASE II CLINICAL TRIAL WITH AN AMPA‐POSITIVE ALLOSTERIC MODULATOR (S 47445): BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS SUFFERING FROM ALZHEIMER's DISEASE AT MILD TO MODERATE STAGES WITH DEPRESSIVE SYMPTOMS
Author(s) -
Cummings Jeffrey L.,
Bernard Katy,
Bretin Sylvie,
Gouttefangeas Sylvie,
Pueyo Maria
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.195
Subject(s) - depression (economics) , dementia , memantine , medicine , population , geriatric depression scale , antidepressant , adverse effect , disease , psychiatry , psychology , cognition , depressive symptoms , hippocampus , environmental health , economics , macroeconomics